BR0307882A - Métodos para detectar a presença de um agente adventìcio em uma composição compreendendo um reovìrus e um vìrus, e para validar uma composição compreendendo um microorganismo, e, célula indicadora útil para detectar um agente adventìcio em uma composição de microorganismo - Google Patents

Métodos para detectar a presença de um agente adventìcio em uma composição compreendendo um reovìrus e um vìrus, e para validar uma composição compreendendo um microorganismo, e, célula indicadora útil para detectar um agente adventìcio em uma composição de microorganismo

Info

Publication number
BR0307882A
BR0307882A BR0307882-5A BR0307882A BR0307882A BR 0307882 A BR0307882 A BR 0307882A BR 0307882 A BR0307882 A BR 0307882A BR 0307882 A BR0307882 A BR 0307882A
Authority
BR
Brazil
Prior art keywords
composition
microorganism
detecting
adventitious agent
agent
Prior art date
Application number
BR0307882-5A
Other languages
English (en)
Inventor
Matthew C Coffey
Original Assignee
Oncolytics Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc
Publication of BR0307882A publication Critical patent/BR0307882A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/337—Ribozyme
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/14—Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)

Abstract

"MéTODOS PARA DETECTAR A PRESENçA DE UM AGENTE ADVENTìCIO EM UMA COMPOSIçãO COMPREENDENDO UM REOVìRUS E UM VìRUS, E PARA VALIDAR UMA COMPOSIçãO COMPREENDENDO UM MICROORGANISMO, E, CéLULA INDICADORA úTIL PARA DETECTAR UM AGENTE ADVENTìCIO EM UMA COMPOSIçãO DE MICROORGANISMO". A presente invenção proporciona um método de detectar agentes adventícios em uma composição compreendendo um microorganismo através do uso de células indicadoras expressando ribozima, e também células indicadoras úteis em uma detecção do tipo referido.
BR0307882-5A 2002-02-28 2003-02-26 Métodos para detectar a presença de um agente adventìcio em uma composição compreendendo um reovìrus e um vìrus, e para validar uma composição compreendendo um microorganismo, e, célula indicadora útil para detectar um agente adventìcio em uma composição de microorganismo BR0307882A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36073002P 2002-02-28 2002-02-28
PCT/CA2003/000264 WO2003072811A2 (en) 2002-02-28 2003-02-26 The use of ribozymes in the detection of adventitious agents

Publications (1)

Publication Number Publication Date
BR0307882A true BR0307882A (pt) 2004-12-28

Family

ID=27766245

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307882-5A BR0307882A (pt) 2002-02-28 2003-02-26 Métodos para detectar a presença de um agente adventìcio em uma composição compreendendo um reovìrus e um vìrus, e para validar uma composição compreendendo um microorganismo, e, célula indicadora útil para detectar um agente adventìcio em uma composição de microorganismo

Country Status (17)

Country Link
EP (2) EP2439286A1 (pt)
JP (3) JP4369243B2 (pt)
AR (1) AR038849A1 (pt)
AT (1) ATE519860T1 (pt)
AU (1) AU2003206587B2 (pt)
BR (1) BR0307882A (pt)
CA (1) CA2374388C (pt)
DE (1) DE03704136T1 (pt)
DK (1) DK1481084T3 (pt)
ES (1) ES2241506T3 (pt)
HK (1) HK1067664A1 (pt)
MX (1) MXPA04008277A (pt)
NZ (1) NZ534488A (pt)
TR (1) TR200501513T3 (pt)
TW (1) TWI329132B (pt)
WO (1) WO2003072811A2 (pt)
ZA (1) ZA200406231B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10131845B4 (de) 2001-06-30 2005-08-25 Hella Kgaa Hueck & Co. Schaltungseinrichtung für die Spannungsversorgung von Leuchtdioden in einem Kraftfahrzeug
CN1306959C (zh) * 2004-09-21 2007-03-28 中国科学院武汉病毒研究所 草鱼呼肠孤病毒抗原亚单位疫苗制备方法
US10668119B2 (en) 2005-08-01 2020-06-02 Virocure, Inc. Attenuated reovirus
EP1917351A4 (en) 2005-08-01 2009-12-16 Univ Technologies Int ATTENUATED REOVIRUS
US10369171B2 (en) 2007-03-13 2019-08-06 Virocure, Inc. Attenuated reoviruses for selection of cell populations
TWI597499B (zh) * 2009-05-28 2017-09-01 亞培生物股份有限公司 體外病原體檢驗技術

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5254678A (en) 1987-12-15 1993-10-19 Gene Shears Pty. Limited Ribozymes
US5168053A (en) 1989-03-24 1992-12-01 Yale University Cleavage of targeted RNA by RNAase P
US5225347A (en) 1989-09-25 1993-07-06 Innovir Laboratories, Inc. Therapeutic ribozyme compositions and expression vectors
US5225337A (en) 1989-09-25 1993-07-06 Innovir Laboratories, Inc. Ribozyme compositions and methods for use
WO1994001549A1 (en) 1992-07-02 1994-01-20 Sankyo Company, Limited Looped, hairpin ribozyme
AU679525B2 (en) * 1992-12-04 1997-07-03 Innovir Laboratories, Inc. Regulatable nucleic acid therapeutic and methods of use thereof
DK0931830T3 (da) 1993-02-16 2001-06-11 Onyx Pharma Inc Cytopatiske vira til terapi og profylakse af neoplasi
EP1486211B1 (en) 1993-04-30 2008-10-22 Wellstat Biologics Corporation Compositions for treating cancer using viruses
WO1995010608A1 (en) * 1993-10-15 1995-04-20 Foundation For Research And Technology - Hellas (Fo.R.T.H.) Asymmetric hammerhead ribozymes and nucleotide sequences for their construction
US5631359A (en) 1994-10-11 1997-05-20 Ribozyme Pharmaceuticals, Inc. Hairpin ribozymes
US6107027A (en) * 1994-12-14 2000-08-22 University Of Washington Ribozymes for treating hepatitis C
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
US6136307A (en) 1997-08-13 2000-10-24 Oncolytics Biotech Inc. Reovirus for the treatment of cellular proliferative disorders
ATE371372T1 (de) 1997-10-09 2007-09-15 Wellstat Biologics Corp Behandlung von neoplasmen mit interferon- empfindlichen, klonalen viren
EP1066312A4 (en) 1998-03-28 2002-01-02 Univ Utah Res Found CIRCULAR, HAIRPIN-SHAPED, CIRCULAR / URINAL-SHAPED, LASSO-SHAPED AND HAIRPIN-PINLASSO-SHAPED "HAMMERHEAD" RIBOZYMS
AU6522599A (en) * 1998-10-23 2000-05-15 Children's Medical Center Corporation Use of a self-cleaving rna motif to modulate gene expression
US7122645B2 (en) * 2000-03-27 2006-10-17 Smithkline Beecham Corporation Detection of viable agents
TWI289158B (en) * 2000-08-10 2007-11-01 Oncolytics Biotech Inc Method of producing infectious reovirus

Also Published As

Publication number Publication date
WO2003072811A2 (en) 2003-09-04
AU2003206587B2 (en) 2007-03-15
TWI329132B (en) 2010-08-21
JP4369243B2 (ja) 2009-11-18
EP1481084A2 (en) 2004-12-01
AR038849A1 (es) 2005-01-26
DK1481084T3 (da) 2011-09-26
EP1481084B1 (en) 2011-08-10
JP2009005712A (ja) 2009-01-15
JP2012125257A (ja) 2012-07-05
CA2374388C (en) 2005-07-12
ES2241506T3 (es) 2011-12-13
MXPA04008277A (es) 2004-11-10
ZA200406231B (en) 2005-11-30
JP5615865B2 (ja) 2014-10-29
TW200404099A (en) 2004-03-16
DE03704136T1 (de) 2005-12-15
EP2439286A1 (en) 2012-04-11
CA2374388A1 (en) 2003-08-28
NZ534488A (en) 2008-04-30
WO2003072811A3 (en) 2004-02-05
HK1067664A1 (en) 2005-04-15
AU2003206587A1 (en) 2003-09-09
ES2241506T1 (es) 2005-11-01
ATE519860T1 (de) 2011-08-15
JP2005518797A (ja) 2005-06-30
TR200501513T3 (tr) 2005-06-21

Similar Documents

Publication Publication Date Title
BR0112871A (pt) Detecção de analitos para ambientes aquosos
ATE514944T1 (de) Verfahren zum nachweis von oxidierenden substanzen
BRPI0409410A (pt) material em partìcula contendo elastÈmero termoplástico e métodos para fabricação e uso do mesmo
TW200512457A (en) Method of diagnosing SARS corona virus infection
BR112012031071A2 (pt) 8-proteínas de ligação à il-1
EP1979000A4 (en) METHOD FOR DETECTING CANCER CELLS USING A VIRUS
BR0115715A (pt) Análise de expressão de ácidos nucleìcos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
WO2005115115A3 (en) Method of measuring cancer susceptibility
EP1071827A4 (en) DIAGNOSTIC SYSTEMS USING MIXED CELL CULTURES
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
WO2006017751A3 (en) Methods for the detection of molecular interactions within cells
TR199900195T2 (xx) S�tmaya kar�� a�� kompozisyonu.
WO2005098449A3 (en) Hausp-mdm2 interaction and uses thereof
BRPI0513596B8 (pt) método e kit para detectar uma infecção micobacteriana em uma amostra de um indivíduo de interesse por meio da detecção de antígeno micobacteriano
BR0307882A (pt) Métodos para detectar a presença de um agente adventìcio em uma composição compreendendo um reovìrus e um vìrus, e para validar uma composição compreendendo um microorganismo, e, célula indicadora útil para detectar um agente adventìcio em uma composição de microorganismo
DE602004030824D1 (de) An der oberfläche befindliche campylobacter jejuni-polypeptide
ATE326982T1 (de) Testsystem zur evaluierung der kompatibilität biologisch aktiver substanzen mit copolymeren
BRPI0417037A (pt) métodos de classificação de toxicidade retiniana
Kamar Hepatitis e virus infection in Iranian kidney-transplant patients
CUI et al. Study on Measurement Method of Radiation Field of Flaw Detection Accelerator
Huang et al. Background Studies for the LUX-ZEPLIN Dark Matter Experiment
WO2023004204A3 (en) Use of circulating cell-free methylated dna to detect tissue damage
Marcotulli et al. The Density of Blazars above 100 MeV and the Origin of the Extragalactic Gamma-ray Background
Brown et al. Laboratory measurements of the x-ray emission following dielectronic recombination onto highly charged argon ions
Deantonio Measurement of Ultraviolet Radiation Exposure Using Methylene Blue and PvP

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2112 DE 28/06/2011.